selected publications
-
Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2024
Academic Article
GET IT
Times cited: 2 -
Quantitative Systems Toxicology Modeling Informed Safe Dose Selection of Emvododstat in Acute Myeloid Leukemia Patients.
Clinical pharmacology and therapeutics.
2023
Academic Article
GET IT
Times cited: 6